Rituximab in lupus anticoagulant hypoprothrombinemia syndrome: A case report
After 1-year, complete remission of clinical symptoms was achieved, with normalization of FII and FIX values and moderate reduction of aPS/PT titers, especially IgM isotype.
Authors
- Vittorio Pengo (ORCID: https://orcid.org/0000-0003-2064-6071)
- Jacopo Agnelli Giacchello (ORCID: https://orcid.org/0000-0002-4671-9331)
- Roberto Santi (ORCID: https://orcid.org/0000-0002-3463-2749)
- Nicol Francesca Trincheri
- Laura Contino (ORCID: https://orcid.org/0009-0006-2112-715X)
- Patrizia Sciancalepore
Institutions
- University of Padua (IT)
- Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo (IT)
Publication Details
- Journal
- Lupus
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1177/09612033241299619
- Citations
- 2
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.94